RYR2 and catecholaminergic polymorphic ventricular tachycardia: Our previous studies showed that depending on their locations, some CPVT-associated RyR2 mutations enhance the Ca2+ dependent activation of [3H]ryanodine binding, while other CPVT-associated RyR2 mutations do not [16, 17].